206 results
Page 4 of 11
8-K
EX-99.1
dwqvh3y1 nnppmkw
12 Feb 21
Note Regarding Forward-looking Statements
8:19am
FWP
g9sgi s3fyaowpe
11 Feb 21
Free writing prospectus
9:56pm
FWP
d912u6rnf7
11 Feb 21
Free writing prospectus
5:29pm
424B5
v1kml34nb6y szy0zb1p
11 Feb 21
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
sym7 qd2ymkbna
12 Nov 20
Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates
4:57pm
424B2
4ifke82fizc2rl9jiz
2 Oct 20
Prospectus for primary offering
4:16pm
8-K
EX-99.1
pqdq4o2emlhum2
10 Aug 20
Diffusion Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
5:00pm
424B3
qaog cm5vo6bbf73k
8 Jun 20
Prospectus supplement
4:48pm
8-K
EX-99.1
jlr10o4r
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
8-K
EX-10.1
l89h o4rzcsdc0q
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
8-K
32ghmee9
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
8-K
EX-99.2
v384gmn
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm